Waft Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 21-12-2024
- Paid Up Capital ₹ 2.00 M
as on 21-12-2024
- Company Age 7 Year, 2 Months
- Last Filing with ROC 31 Mar 2022
- Revenue %
(FY 2019)
- Net Worth 312.83%
(FY 2019)
- Total Assets 357.14%
(FY 2019)
About Waft Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 2.00 M, as per Ministry of Corporate Affairs (MCA) records.
Sai Viswanadha, Surya Samsani, Santhi Tumati, and Two other members serve as directors at the Company.
- CIN/LLPIN
U33100AP2017PTC106922
- Company No.
106922
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Oct 2017
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Godavari, Andhra Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Waft Pharma?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkata Gidugu  | Director | 21-Oct-2020 | Current |
| Sai Viswanadha | Director | 26-Oct-2017 | Current |
| Surya Samsani | Director | 26-Oct-2017 | Current |
| Santhi Tumati | Director | 26-Oct-2017 | Current |
| Venkata Tumati | Director | 31-Mar-2018 | Current |
Financial Performance of Waft Pharma.
Waft Pharma Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 312.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Waft Pharma?
In 2019, Waft Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Waft Pharma?
Unlock and access historical data on people associated with Waft Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Waft Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Waft Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
